INS and metabolic dysfunction-associated steatotic liver disease: Since insulin resistance plays a key role in NAFLD pathogenesis by increasing lipolysis in adipose tissue and delivering more free fatty acids to the liver, enhancing insulin sensitivity may significantly reduce NAFLD risk (9, 26).